228 related articles for article (PubMed ID: 30527766)
1. Risk factors for cardiovascular disease in heterozygous familial hypercholesterolemia: A systematic review and meta-analysis.
Akioyamen LE; Genest J; Chu A; Inibhunu H; Ko DT; Tu JV
J Clin Lipidol; 2019; 13(1):15-30. PubMed ID: 30527766
[TBL] [Abstract][Full Text] [Related]
2. Differences in characteristics and risk of cardiovascular disease in familial hypercholesterolemia patients with and without tendon xanthomas: a systematic review and meta-analysis.
Oosterveer DM; Versmissen J; Yazdanpanah M; Hamza TH; Sijbrands EJ
Atherosclerosis; 2009 Dec; 207(2):311-7. PubMed ID: 19439299
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular disease in familial hypercholesterolemia: Validation and refinement of the Montreal-FH-SCORE.
Paquette M; Brisson D; Dufour R; Khoury É; Gaudet D; Baass A
J Clin Lipidol; 2017; 11(5):1161-1167.e3. PubMed ID: 28801029
[TBL] [Abstract][Full Text] [Related]
4. Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers.
Besseling J; Kindt I; Hof M; Kastelein JJ; Hutten BA; Hovingh GK
Atherosclerosis; 2014 Mar; 233(1):219-23. PubMed ID: 24529147
[TBL] [Abstract][Full Text] [Related]
5. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia.
Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2632-2640. PubMed ID: 34433300
[TBL] [Abstract][Full Text] [Related]
6. Value of the Definition of Severe Familial Hypercholesterolemia for Stratification of Heterozygous Patients.
Pérez-Calahorra S; Sánchez-Hernández RM; Plana N; Marco-Benedi V; Pedro-Botet J; Almagro F; Brea A; Ascaso JF; Lahoz C; Civeira F;
Am J Cardiol; 2017 Mar; 119(5):742-748. PubMed ID: 28081939
[TBL] [Abstract][Full Text] [Related]
7. Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis.
Akioyamen LE; Genest J; Shan SD; Reel RL; Albaum JM; Chu A; Tu JV
BMJ Open; 2017 Sep; 7(9):e016461. PubMed ID: 28864697
[TBL] [Abstract][Full Text] [Related]
8. Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort.
Allard MD; Saeedi R; Yousefi M; Frohlich J
Lipids Health Dis; 2014 Apr; 13():65. PubMed ID: 24712315
[TBL] [Abstract][Full Text] [Related]
9. Diabetes is associated with an increased risk of cardiovascular disease in patients with familial hypercholesterolemia.
Paquette M; Bernard S; Ruel I; Blank DW; Genest J; Baass A
J Clin Lipidol; 2019; 13(1):123-128. PubMed ID: 30318454
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein(a) is an independent risk factor for cardiovascular disease in heterozygous familial hypercholesterolemia.
Holmes DT; Schick BA; Humphries KH; Frohlich J
Clin Chem; 2005 Nov; 51(11):2067-73. PubMed ID: 16141286
[TBL] [Abstract][Full Text] [Related]
11. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients.
Jansen AC; van Aalst-Cohen ES; Tanck MW; Trip MD; Lansberg PJ; Liem AH; van Lennep HW; Sijbrands EJ; Kastelein JJ
J Intern Med; 2004 Dec; 256(6):482-90. PubMed ID: 15554949
[TBL] [Abstract][Full Text] [Related]
12. Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects.
Beheshti SO; Madsen CM; Varbo A; Nordestgaard BG
J Am Coll Cardiol; 2020 May; 75(20):2553-2566. PubMed ID: 32439005
[TBL] [Abstract][Full Text] [Related]
13. The Montreal-FH-SCORE: A new score to predict cardiovascular events in familial hypercholesterolemia.
Paquette M; Dufour R; Baass A
J Clin Lipidol; 2017; 11(1):80-86. PubMed ID: 28391914
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E genotype is not associated with cardiovascular disease in heterozygous subjects with familial hypercholesterolemia.
Mozas P; Castillo S; Reyes G; Tejedor D; Civeira F; García-Alvarez I; Puzo J; Cenarro A; Alonso R; Mata P; Pocoví M;
Am Heart J; 2003 Jun; 145(6):999-1005. PubMed ID: 12796755
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
Rizos CV; Elisaf MS; Skoumas I; Tziomalos K; Kotsis V; Rallidis L; Garoufi A; Athyros VG; Skalidis E; Kolovou G; Koutagiar I; Papagianni M; Antza C; Katsiki N; Ganotakis E; Liberopoulos EN
Atherosclerosis; 2018 Oct; 277():308-313. PubMed ID: 30270064
[TBL] [Abstract][Full Text] [Related]
16. Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia.
Paquette M; Chong M; Thériault S; Dufour R; Paré G; Baass A
J Clin Lipidol; 2017; 11(3):725-732.e5. PubMed ID: 28456682
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Disease Risk Associated With Familial Hypercholesterolemia: A Systematic Review of the Literature.
Wong B; Kruse G; Kutikova L; Ray KK; Mata P; Bruckert E
Clin Ther; 2016 Jul; 38(7):1696-709. PubMed ID: 27261205
[TBL] [Abstract][Full Text] [Related]
18. Comorbidities with Familial Hypercholesterolemia (FH): A Systematic Review.
Vaseghi G; Javanmard SH; Heshmat-Ghahdarijani K; Sarrafzadegan N; Amerizadeh A
Curr Probl Cardiol; 2023 May; 48(5):101109. PubMed ID: 35007640
[TBL] [Abstract][Full Text] [Related]
19. Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
Pérez de Isla L; Alonso R; Mata N; Fernández-Pérez C; Muñiz O; Díaz-Díaz JL; Saltijeral A; Fuentes-Jiménez F; de Andrés R; Zambón D; Piedecausa M; Cepeda JM; Mauri M; Galiana J; Brea Á; Sanchez Muñoz-Torrero JF; Padró T; Argueso R; Miramontes-González JP; Badimón L; Santos RD; Watts GF; Mata P
Circulation; 2017 May; 135(22):2133-2144. PubMed ID: 28275165
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
